Brief: Rhythm Biosciences Says CEO And Managing Director Glenn Gilbert Resigned
19/04/2023 02:18
April 19 (Reuters) - Rhythm Biosciences Ltd RHY.AX :
* RESIGNATION OF CHIEF EXECUTIVE OFFICER AND MANAGING
DIRECTOR,
GLENN GILBERT
* EXECUTIVE CHAIRMAN, OTTO BUTTULA TO ASSUME FURTHER
EXECUTIVE
DUTIES
Source text for Eikon: ID:nASX36pkCq
Further company coverage: RHY.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rhythm Biosciences
See all newsBrief: Rhythm Biosciences Says Gavin Fox-Smith Resigns As Chair
Brief: Rhythm Biosciences Announces Appointment Of Non-Executive Directors
Australia's Rhythm Biosciences rises on accelerating commercialisation of cancer test
Brief: Rhythm Biosciences Executes Distribution Agreement For Genetype
Brief: Rhythm Biosciences Seeks Trading Halt